Renaissance Technologies
IMCR icon

Renaissance Technologies’s Immunocore IMCR Stock Holding History

Renaissance Technologies’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Sell
102,400
-61,600
-38% -$1.82M ﹤0.01% 1696
2026
Q1 		$4.94M Buy
164,000
+23,100
+16% +$747K 0.01% 1388
2025
Q4 		$4.89M Sell
140,900
-1,870
-1% -$66K 0.01% 1320
2025
Q3 		$5.19M Sell
142,770
-79,282
-36% -$2.69M 0.01% 1473
2025
Q2 		$6.97M Buy
222,052
+131,482
+145% +$4.08M 0.01% 1311
2025
Q1 		$2.69M Sell
90,570
-6,000
-6% -$180K ﹤0.01% 1809
2024
Q4 		$2.85M Sell
96,570
-179,630
-65% -$5.68M ﹤0.01% 1817
2024
Q3 		$8.6M Sell
276,200
-370,720
-57% -$13.5M 0.01% 1119
2024
Q2 		$21.9M Buy
646,920
+82,120
+15% +$4.19M 0.04% 549
2024
Q1 		$36.7M Buy
564,800
+219,700
+64% +$15.1M 0.06% 410
2023
Q4 		$23.6M Sell
345,100
-111,200
-24% -$5.78M 0.04% 553
2023
Q3 		$23.7M Buy
456,300
+9,000
+2% +$533K 0.04% 510
2023
Q2 		$26.8M Buy
447,300
+2,700
+0.6% +$154K 0.04% 539
2023
Q1 		$22M Buy
444,600
+139,500
+46% +$7.84M 0.03% 666
2022
Q4 		$17.4M Buy
305,100
+210,300
+222% +$11.8M 0.02% 788
2022
Q3 		$4.45M Buy
94,800
+43,900
+86% +$2.09M 0.01% 1512
2022
Q2 		$1.9M Buy
50,900
+43,600
+597% +$1.42M ﹤0.01% 2223
2022
Q1 		$218K Buy
+7,300
New +$184K ﹤0.01% 3610

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Renaissance Technologies's IMCR Position: Q2 2026 in Review

Renaissance Technologies reduced its Immunocore (IMCR) stake by 38% in Q2 2026, selling an estimated $1.82M and leaving 102,400 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Renaissance Technologies first reported a position in IMCR in Q1 2022 and has held it in 18 quarters since. The position peaked at $36.7M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Renaissance Technologies held 102,400 shares of Immunocore worth $3.25M as of Q2 2026.
  • Renaissance Technologies sold 61,600 Immunocore shares in Q2 2026, an estimated $1.82M.
  • Immunocore made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1696 holding.
  • Renaissance Technologies first reported a position in Immunocore in Q1 2022 and has held it in 18 quarters since.
  • Renaissance Technologies's Immunocore position peaked at $36.7M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.